Trial site
WIP Warsaw IBD Point Profesor Kierkuś
- 8running trials
- 7closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease6 trials
- Ulcerative colitis5 trials
- Coeliac disease1 trial
- Migraine1 trial
- Phase
- Phase 39 trials
- Phase 24 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Completed7 trials
- Active, not recruiting5 trials
- Recruiting3 trials
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Hoffmann-La Roche2 trials
- Pfizer2 trials
- Takeda2 trials
- AbbVie1 trial
- and 5 more
Running trials
Active, not recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Active, not recruiting
Study of GS-5290 in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Recruiting
Active, not recruiting
Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease
Recruiting
Recruiting
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease1 recruiting
Closed trials
Completed
Completed
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Completed
Completed
Completed
A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Completed
Active, not recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026